Residual Inflammatory Risk in Outcomes of Chinese Patients After Percutaneous Coronary Intervention

Miao Yu; Yuan-Fan Yuan; Fen Yang; Jia-Hao Xu; Mei-Lin Liu; Shao-Fang Nie; Yu-Yan Xiong; Peter Libby; Xiang Cheng

doi:10.1016/j.jacasi.2024.05.004

Residual Inflammatory Risk in Outcomes of Chinese Patients After Percutaneous Coronary Intervention

JACC Asia. 2024 Jul 23;4(8):636-638. doi: 10.1016/j.jacasi.2024.05.004. eCollection 2024 Aug.

Authors

Miao Yu^{1

2

3}, Yuan-Fan Yuan^{1

2

3}, Fen Yang^{1

2

3}, Jia-Hao Xu^{1

2

3}, Mei-Lin Liu^{1

2

3}, Shao-Fang Nie^{1

2

3}, Yu-Yan Xiong^{1

2

3}, Peter Libby⁴, Xiang Cheng^{1

2

3}

Affiliations

¹ Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁴ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Grants and funding